Ruffmann R, Seifert R, Ross H, Haass H G
Laryngol Rhinol Otol (Stuttg). 1981 May;60(5):271-4.
13 patients with far advanced squamous cell carcinoma of the head and neck were treated with a low dose combination chemotherapy of Vincristine, Bleomycin and Methrotrexate during 7--8 weeks prior to surgery or radio-therapy. V-B-M was given as an out- patient regimen. 9 patients were treated the first time ever, 4 patients suffered of tumor-recurrence. 5 patients i.e. 38% achieved complete remission of all measurable disease, a total of 9 patients i.e. 69% achieved a partial remission of more than 50%. Prior treatment or localisation of tumor did not influence the results. Competent application warranted, toxicity was mild. The significance of pre-operatively achieved complete remission is discussed. Short-term follow up does not yet permit any statement upon survival.
13例晚期头颈部鳞状细胞癌患者在手术或放疗前7至8周接受了长春新碱、博来霉素和甲氨蝶呤的低剂量联合化疗。V-B-M作为门诊治疗方案给药。9例患者为首次治疗,4例患者有肿瘤复发。5例患者(即38%)实现了所有可测量病灶的完全缓解,总共9例患者(即69%)实现了超过50%的部分缓解。先前的治疗或肿瘤定位不影响结果。在合理应用的情况下,毒性较轻。讨论了术前实现完全缓解的意义。短期随访尚无法对生存情况作出任何说明。